Generic drug
Mycophenolate mofetil price, strengths & recalls
Generic of Cellcept
Pharmacies pay $7.59 for 30 tablets of Mycophenolate mofetil 500 mg tablet this week, and from $4.04 to $205.93 across its 3 priced strengths and forms. 33 manufacturers make it. 2 recalls are ongoing. Its official label last changed on November 6, 2026.
2 open recallsGeneric- Fair cash price
- $19.23
- Strengths
- 3
- Makers
- 33
- Updated
- Nov 11
Mycophenolate mofetil price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 250 mg capsule | $0.1347 | $4.04 / 30 capsules | ||
| 500 mg injection | Not priced this week | |||
| 200 mg/mL oral suspension | $0.9153 | $205.93 / 225 mL | ||
| 500 mg tablet | $0.2530 | $7.59 / 30 tablets | ||
The lowest cost per capsule is 250 mg capsule at $0.1347. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Brand names of mycophenolate mofetil
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Supply status: shortages & recalls
Recalls
Showing the 6 most relevant of 11 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Mycophenolate mofetil
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use MYCOPHENOLATE MOFETIL safely and effectively. See full prescribing information for MYCOPHENOLATE MOFETIL.MYCOPHENOLATE MOFETIL capsules, for oral useMYCOPHENOLATE MOFETIL tablets, for oral useInitial U.S. Approval: 1995
WARNING: EMBRYOFETAL TOXICITY, MALIGNANCIES, and SERIOUS INFECTIONS
•
Use during pregnancy is associated with increased risks of first trimester pregnancy loss and congenital malformations. Avoid if safer treatment options are available. Females of reproductive potential must be counseled regarding pregnancy prevention and planning [see Warnings and Precautions (5.1), Use in Special Populations (8.1, 8.3)].
•
Increased risk of development of lymphoma and other malignancies, particularly of the skin [see Warnings and Precautions (5.2)].
•
Increased susceptibility to bacterial, viral, fungal and protozoal infections, including opportunistic infections and viral reactivation of hepatitis B and C, which may lead to hospitalizations and fatal outcomes [see Warnings and Precautions (5.3)].
WARNING: EMBRYOFETAL TOXICITY, MALIGNANCIES and SERIOUS INFECTIONS
See full prescribing information for complete boxed warning.
•
Use during pregnancy is associated with increased risks of first trimester pregnancy loss and congenital malformations. Avoid if safer treatment options are available. Females of reproductive potential must be counseled regarding pregnancy prevention and planning [see Warnings and Precautions (5.1)].
•
Increased risk of development of lymphoma and other malignancies, particularly of the skin [see Warnings and Precautions (5.2)].
•
Increased susceptibility to infections, including opportunistic infections and severe infections with fatal outcomes [see Warnings and Precautions (5.3)].
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA050722 · Roche Palo
- First approved
- May 3, 1995 (31 years ago)
- Latest approved change
- July 29, 2026
- Approved label
- PDF, Aug 4, 2026
- Generic makers
- 29 approved generic applications on the market
Mycophenolate mofetil questions
How much does mycophenolate mofetil cost without insurance?
Pharmacies pay about $7.59 for 30 tablets of mycophenolate mofetil 500 mg tablet ($0.2530 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $19.23. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of mycophenolate mofetil?
Mycophenolate mofetil is sold as Cellcept. The generic has the same active ingredient and usually costs far less.
Is mycophenolate mofetil in shortage?
No shortage is reported for mycophenolate mofetil right now. We check the national shortage list every day.
Has mycophenolate mofetil been recalled?
11 recalls on record, 2 ongoing. Recalls name specific lots - check yours.
When did the mycophenolate mofetil label last change?
The official label was last updated on November 6, 2026 (version 21). See what changed.
Talk about mycophenolate mofetil
No comments yet. Questions, tips, what worked for you - start the conversation.